HEADER HYDROLASE 10-JUL-12 4B1H TITLE STRUCTURE OF HUMAN PARG CATALYTIC DOMAIN IN COMPLEX WITH ADP-RIBOSE COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY(ADP-RIBOSE) GLYCOHYDROLASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 448-976; COMPND 5 EC: 3.2.1.143; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A-6HIS KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR C.BRASSINGTON,J.ELLSTON,G.HASSALL,G.HOLDGATE,M.MCALISTER,G.SMITH, AUTHOR 2 J.A.TUCKER,M.WATSON REVDAT 4 20-DEC-23 4B1H 1 REMARK HETSYN LINK REVDAT 3 04-APR-18 4B1H 1 REMARK REVDAT 2 16-JAN-13 4B1H 1 JRNL REVDAT 1 19-DEC-12 4B1H 0 JRNL AUTH J.A.TUCKER,N.BENNETT,C.BRASSINGTON,S.T.DURANT,G.HASSALL, JRNL AUTH 2 G.HOLDGATE,M.MCALISTER,J.W.M.NISSINK,C.TRUMAN,M.WATSON JRNL TITL STRUCTURES OF THE HUMAN POLY (ADP-RIBOSE) GLYCOHYDROLASE JRNL TITL 2 CATALYTIC DOMAIN CONFIRM CATALYTIC MECHANISM AND EXPLAIN JRNL TITL 3 INHIBITION BY ADP-HPD DERIVATIVES. JRNL REF PLOS ONE V. 7 50889 2012 JRNL REFN ESSN 1932-6203 JRNL PMID 23251397 JRNL DOI 10.1371/JOURNAL.PONE.0050889 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 37234 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1961 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2470 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.61 REMARK 3 BIN R VALUE (WORKING SET) : 0.3500 REMARK 3 BIN FREE R VALUE SET COUNT : 135 REMARK 3 BIN FREE R VALUE : 0.4010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4071 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 81 REMARK 3 SOLVENT ATOMS : 378 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.31000 REMARK 3 B22 (A**2) : 0.46000 REMARK 3 B33 (A**2) : 0.85000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.200 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.170 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.100 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.390 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4346 ; 0.015 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 2983 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5909 ; 1.414 ; 1.950 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7220 ; 2.262 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 528 ;10.388 ; 5.050 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 203 ;36.261 ;23.100 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 716 ;13.470 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;14.110 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 635 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4832 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 933 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2595 ; 0.762 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1041 ; 0.196 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4199 ; 1.356 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1751 ; 2.131 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1710 ; 3.289 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 451 A 1603 REMARK 3 ORIGIN FOR THE GROUP (A): 17.9681 2.8058 8.4344 REMARK 3 T TENSOR REMARK 3 T11: 0.0321 T22: 0.0797 REMARK 3 T33: 0.0055 T12: -0.0004 REMARK 3 T13: -0.0108 T23: -0.0090 REMARK 3 L TENSOR REMARK 3 L11: 0.7722 L22: 1.1207 REMARK 3 L33: 0.3504 L12: -0.2279 REMARK 3 L13: -0.0521 L23: -0.0965 REMARK 3 S TENSOR REMARK 3 S11: -0.0191 S12: -0.0829 S13: -0.0036 REMARK 3 S21: 0.0507 S22: 0.0384 S23: -0.0014 REMARK 3 S31: 0.0457 S32: 0.0103 S33: -0.0193 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4B1H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JUL-12. REMARK 100 THE DEPOSITION ID IS D_1290053299. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : VARIMAXHF REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39298 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 27.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 6.150 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.84 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 4A0D REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 3350, 36.4MM PCTP-4, 63.6MM REMARK 280 PCTP-10, 0.2M AMMONIUM SULPHATE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.46450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.48750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.32800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.48750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.46450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.32800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 446 REMARK 465 SER A 447 REMARK 465 SER A 448 REMARK 465 PRO A 449 REMARK 465 ASP A 450 REMARK 465 GLU A 524 REMARK 465 ASP A 525 REMARK 465 GLU A 526 REMARK 465 ASN A 527 REMARK 465 GLY A 528 REMARK 465 GLU A 529 REMARK 465 ALA A 964 REMARK 465 GLU A 965 REMARK 465 THR A 966 REMARK 465 ALA A 967 REMARK 465 ASP A 968 REMARK 465 HIS A 969 REMARK 465 SER A 970 REMARK 465 GLY A 971 REMARK 465 GLN A 972 REMARK 465 ARG A 973 REMARK 465 THR A 974 REMARK 465 GLY A 975 REMARK 465 THR A 976 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 469 CG1 CG2 CD1 REMARK 470 ARG A 470 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 503 CD CE NZ REMARK 470 VAL A 523 CG1 CG2 REMARK 470 ARG A 530 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 583 CD OE1 OE2 REMARK 470 LYS A 648 CG CD CE NZ REMARK 470 ARG A 710 NE CZ NH1 NH2 REMARK 470 ARG A 830 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 831 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2117 O HOH A 2185 1.98 REMARK 500 OH TYR A 929 O HOH A 2333 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 592 -56.70 -129.51 REMARK 500 CYS A 608 78.08 -103.28 REMARK 500 SER A 651 -64.97 -95.60 REMARK 500 THR A 716 -165.54 -102.22 REMARK 500 SER A 749 -118.68 -137.48 REMARK 500 LEU A 752 49.04 -159.68 REMARK 500 VAL A 753 -152.81 -111.27 REMARK 500 ASN A 762 77.54 -116.96 REMARK 500 TYR A 795 143.84 -172.16 REMARK 500 ALA A 796 -121.85 49.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 DTV: DTT FROM PROTEIN BUFFER DERIVATISES CYSTEINE TO FORM REMARK 600 (2R)-2-AZANIUMYL-3-[[(2S,3S)-2,3-DIHYDROXY-4-SULFANYL] REMARK 600 PROPANOATE REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 AR6 A 1967 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 1603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DTV A 1711 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1964 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1965 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AR6 A 1966 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AR6 A 1967 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1968 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1969 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4A0D RELATED DB: PDB REMARK 900 STRUCTURE OF UNLIGANDED HUMAN PARG CATALYTIC DOMAIN REMARK 900 RELATED ID: 4B1G RELATED DB: PDB REMARK 900 STRUCTURE OF UNLIGANDED HUMAN PARG CATALYTIC DOMAIN REMARK 900 RELATED ID: 4B1I RELATED DB: PDB REMARK 900 STRUCTURE OF UNLIGANDED HUMAN PARG CATALYTIC DOMAIN REMARK 900 RELATED ID: 4B1J RELATED DB: PDB REMARK 900 STRUCTURE OF UNLIGANDED HUMAN PARG CATALYTIC DOMAIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 CODON OPTIMISED SEQUENCE, SIX MUTATIONS INTRODUCED TO REMARK 999 ENHANCE CRYSTALLISABILITY K617A,Q618A,K619A,E688A,K689A, REMARK 999 K690A DBREF 4B1H A 448 976 UNP Q86W56 PARG_HUMAN 448 976 SEQADV 4B1H GLY A 446 UNP Q86W56 EXPRESSION TAG SEQADV 4B1H SER A 447 UNP Q86W56 EXPRESSION TAG SEQADV 4B1H ALA A 616 UNP Q86W56 LYS 616 ENGINEERED MUTATION SEQADV 4B1H ALA A 617 UNP Q86W56 GLN 617 ENGINEERED MUTATION SEQADV 4B1H ALA A 618 UNP Q86W56 LYS 618 ENGINEERED MUTATION SEQADV 4B1H ALA A 688 UNP Q86W56 GLU 688 ENGINEERED MUTATION SEQADV 4B1H ALA A 689 UNP Q86W56 LYS 689 ENGINEERED MUTATION SEQADV 4B1H ALA A 690 UNP Q86W56 LYS 690 ENGINEERED MUTATION SEQRES 1 A 531 GLY SER SER PRO ASP LYS LYS TRP LEU GLY THR PRO ILE SEQRES 2 A 531 GLU GLU MET ARG ARG MET PRO ARG CSO GLY ILE ARG LEU SEQRES 3 A 531 PRO LEU LEU ARG PRO SER ALA ASN HIS THR VAL THR ILE SEQRES 4 A 531 ARG VAL ASP LEU LEU ARG ALA GLY GLU VAL PRO LYS PRO SEQRES 5 A 531 PHE PRO THR HIS TYR LYS ASP LEU TRP ASP ASN LYS HIS SEQRES 6 A 531 VAL LYS MET PRO CYS SER GLU GLN ASN LEU TYR PRO VAL SEQRES 7 A 531 GLU ASP GLU ASN GLY GLU ARG THR ALA GLY SER ARG TRP SEQRES 8 A 531 GLU LEU ILE GLN THR ALA LEU LEU ASN LYS PHE THR ARG SEQRES 9 A 531 PRO GLN ASN LEU LYS ASP ALA ILE LEU LYS TYR ASN VAL SEQRES 10 A 531 ALA TYR SER LYS LYS TRP ASP PHE THR ALA LEU ILE ASP SEQRES 11 A 531 PHE TRP ASP LYS VAL LEU GLU GLU ALA GLU ALA GLN HIS SEQRES 12 A 531 LEU TYR GLN SER ILE LEU PRO ASP MET VAL LYS ILE ALA SEQRES 13 A 531 LEU CYS LEU PRO ASN ILE CYS THR GLN PRO ILE PRO LEU SEQRES 14 A 531 LEU ALA ALA ALA MET ASN HIS SER ILE THR MET SER GLN SEQRES 15 A 531 GLU GLN ILE ALA SER LEU LEU ALA ASN ALA PHE PHE CYS SEQRES 16 A 531 THR PHE PRO ARG ARG ASN ALA LYS MET LYS SER GLU TYR SEQRES 17 A 531 SER SER TYR PRO ASP ILE ASN PHE ASN ARG LEU PHE GLU SEQRES 18 A 531 GLY ARG SER SER ARG LYS PRO GLU LYS LEU LYS THR LEU SEQRES 19 A 531 PHE CYS TYR PHE ARG ARG VAL THR ALA ALA ALA PRO THR SEQRES 20 A 531 GLY LEU VAL THR PHE THR ARG GLN SER LEU GLU ASP PHE SEQRES 21 A 531 PRO GLU TRP GLU ARG CYS GLU LYS PRO LEU THR ARG LEU SEQRES 22 A 531 HIS VAL THR TYR GLU GLY THR ILE GLU GLU ASN GLY GLN SEQRES 23 A 531 GLY MET LEU GLN VAL ASP PHE ALA ASN ARG PHE VAL GLY SEQRES 24 A 531 GLY GLY VAL THR SER ALA GLY LEU VAL GLN GLU GLU ILE SEQRES 25 A 531 ARG PHE LEU ILE ASN PRO GLU LEU ILE ILE SER ARG LEU SEQRES 26 A 531 PHE THR GLU VAL LEU ASP HIS ASN GLU CYS LEU ILE ILE SEQRES 27 A 531 THR GLY THR GLU GLN TYR SER GLU TYR THR GLY TYR ALA SEQRES 28 A 531 GLU THR TYR ARG TRP SER ARG SER HIS GLU ASP GLY SER SEQRES 29 A 531 GLU ARG ASP ASP TRP GLN ARG ARG CYS THR GLU ILE VAL SEQRES 30 A 531 ALA ILE ASP ALA LEU HIS PHE ARG ARG TYR LEU ASP GLN SEQRES 31 A 531 PHE VAL PRO GLU LYS MET ARG ARG GLU LEU ASN LYS ALA SEQRES 32 A 531 TYR CYS GLY PHE LEU ARG PRO GLY VAL SER SER GLU ASN SEQRES 33 A 531 LEU SER ALA VAL ALA THR GLY ASN TRP GLY CYS GLY ALA SEQRES 34 A 531 PHE GLY GLY ASP ALA ARG LEU LYS ALA LEU ILE GLN ILE SEQRES 35 A 531 LEU ALA ALA ALA ALA ALA GLU ARG ASP VAL VAL TYR PHE SEQRES 36 A 531 THR PHE GLY ASP SER GLU LEU MET ARG ASP ILE TYR SER SEQRES 37 A 531 MET HIS ILE PHE LEU THR GLU ARG LYS LEU THR VAL GLY SEQRES 38 A 531 ASP VAL TYR LYS LEU LEU LEU ARG TYR TYR ASN GLU GLU SEQRES 39 A 531 CYS ARG ASN CYS SER THR PRO GLY PRO ASP ILE LYS LEU SEQRES 40 A 531 TYR PRO PHE ILE TYR HIS ALA VAL GLU SER CYS ALA GLU SEQRES 41 A 531 THR ALA ASP HIS SER GLY GLN ARG THR GLY THR MODRES 4B1H CSO A 467 CYS S-HYDROXYCYSTEINE HET CSO A 467 13 HET BME A1603 4 HET DTV A1711 8 HET GOL A1964 6 HET GOL A1965 6 HET AR6 A1966 36 HET AR6 A1967 11 HET SO4 A1968 5 HET SO4 A1969 5 HETNAM CSO S-HYDROXYCYSTEINE HETNAM BME BETA-MERCAPTOETHANOL HETNAM DTV (2S,3S)-1,4-DIMERCAPTOBUTANE-2,3-DIOL HETNAM GOL GLYCEROL HETNAM AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY- HETNAM 2 AR6 OXOLAN-2-YL]METHYL [HYDROXY-[[(2R,3S,4R,5S)-3,4,5- HETNAM 3 AR6 TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN HETNAM 4 AR6 PHOSPHATE HETNAM SO4 SULFATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN AR6 ADENOSINE-5-DIPHOSPHORIBOSE FORMUL 1 CSO C3 H7 N O3 S FORMUL 2 BME C2 H6 O S FORMUL 3 DTV C4 H10 O2 S2 FORMUL 4 GOL 2(C3 H8 O3) FORMUL 6 AR6 2(C15 H23 N5 O14 P2) FORMUL 8 SO4 2(O4 S 2-) FORMUL 10 HOH *378(H2 O) HELIX 1 1 PRO A 457 MET A 461 5 5 HELIX 2 2 ARG A 485 LEU A 489 5 5 HELIX 3 3 ARG A 535 LEU A 544 1 10 HELIX 4 4 ARG A 549 TYR A 560 1 12 HELIX 5 5 ASN A 561 SER A 565 5 5 HELIX 6 6 PHE A 570 VAL A 580 1 11 HELIX 7 7 GLU A 582 SER A 592 1 11 HELIX 8 8 SER A 592 CYS A 603 1 12 HELIX 9 9 CYS A 603 CYS A 608 1 6 HELIX 10 10 GLN A 627 PHE A 639 1 13 HELIX 11 11 PHE A 661 GLU A 666 5 6 HELIX 12 12 ARG A 671 ALA A 689 1 19 HELIX 13 13 GLU A 707 CYS A 711 5 5 HELIX 14 14 THR A 725 GLY A 730 1 6 HELIX 15 15 VAL A 753 ASN A 762 1 10 HELIX 16 16 PRO A 763 ILE A 766 5 4 HELIX 17 17 ILE A 767 THR A 772 1 6 HELIX 18 18 TYR A 795 TYR A 799 5 5 HELIX 19 19 ARG A 831 PHE A 836 5 6 HELIX 20 20 VAL A 837 LEU A 853 1 17 HELIX 21 21 SER A 858 LEU A 862 5 5 HELIX 22 22 ASP A 878 ALA A 893 1 16 HELIX 23 23 ASP A 904 ARG A 921 1 18 HELIX 24 24 THR A 924 CYS A 940 1 17 HELIX 25 25 LYS A 951 CYS A 963 1 13 SHEET 1 AA10 TRP A 453 GLY A 455 0 SHEET 2 AA10 LEU A 718 THR A 721 -1 O VAL A 720 N LEU A 454 SHEET 3 AA10 VAL A 897 PHE A 900 1 O VAL A 897 N HIS A 719 SHEET 4 AA10 VAL A 865 GLY A 868 1 O VAL A 865 N VAL A 898 SHEET 5 AA10 LEU A 734 ALA A 739 1 O LEU A 734 N ALA A 866 SHEET 6 AA10 GLU A 820 ASP A 825 1 O GLU A 820 N GLN A 735 SHEET 7 AA10 GLU A 779 THR A 784 -1 O LEU A 781 N ALA A 823 SHEET 8 AA10 LEU A 694 SER A 701 -1 O THR A 696 N THR A 784 SHEET 9 AA10 HIS A 621 SER A 626 -1 O HIS A 621 N ARG A 699 SHEET 10 AA10 HIS A 480 VAL A 482 1 O THR A 481 N THR A 624 SHEET 1 AB 2 LEU A 520 PRO A 522 0 SHEET 2 AB 2 ALA A 532 SER A 534 -1 O GLY A 533 N TYR A 521 SHEET 1 AC 2 SER A 790 THR A 793 0 SHEET 2 AC 2 ARG A 800 SER A 804 -1 O ARG A 800 N THR A 793 LINK C ARG A 466 N ACSO A 467 1555 1555 1.33 LINK C ARG A 466 N BCSO A 467 1555 1555 1.34 LINK C ACSO A 467 N GLY A 468 1555 1555 1.34 LINK C BCSO A 467 N GLY A 468 1555 1555 1.33 LINK SG CYS A 603 S2 BME A1603 1555 1555 2.05 LINK SG CYS A 711 S1 DTV A1711 1555 1555 2.03 CISPEP 1 MET A 464 PRO A 465 0 1.46 CISPEP 2 PHE A 498 PRO A 499 0 2.94 SITE 1 AC1 3 CYS A 603 SER A 670 PRO A 673 SITE 1 AC2 5 PRO A 706 CYS A 711 LYS A 713 TYR A 849 SITE 2 AC2 5 HOH A2228 SITE 1 AC3 4 ASN A 740 HIS A 828 PHE A 875 HOH A2268 SITE 1 AC4 4 GLU A 585 HIS A 588 LEU A 589 HOH A2203 SITE 1 AC5 24 ILE A 726 GLU A 727 PHE A 738 ASN A 740 SITE 2 AC5 24 GLY A 745 VAL A 753 GLN A 754 GLU A 755 SITE 3 AC5 24 GLU A 756 TYR A 795 ASN A 869 GLY A 871 SITE 4 AC5 24 CYS A 872 GLY A 873 ALA A 874 PHE A 875 SITE 5 AC5 24 PHE A 902 HOH A2265 HOH A2266 HOH A2301 SITE 6 AC5 24 HOH A2304 HOH A2339 HOH A2375 HOH A2376 SITE 1 AC6 9 PRO A 476 VAL A 482 ILE A 484 ARG A 485 SITE 2 AC6 9 VAL A 486 ASP A 487 PHE A 498 HOH A2032 SITE 3 AC6 9 HOH A2377 SITE 1 AC7 8 ARG A 535 TYR A 564 PRO A 643 ARG A 644 SITE 2 AC7 8 ASN A 646 ARG A 941 ASN A 942 HOH A2166 SITE 1 AC8 3 TRP A 506 ARG A 644 HOH A2068 CRYST1 66.929 90.656 94.975 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014941 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011031 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010529 0.00000